Literature DB >> 12695381

Coexistence of subacute thyroiditis and renal cell carcinoma: a paraneoplastic syndrome.

Ekrem Algün1, Süleyman Alici, Cevat Topal, Serdar Ugras, Reha Erkoç, M Emin Sakarya, Nese Ozbey.   

Abstract

Renal cell carcinoma is characterized by varied manifestations, which include unusual metastatic sites and paraneoplastic and vascular syndromes. We describe the case of a 57-year-old man who presented with high fever, weight loss, palpitations and a tender goitre. We suggest that, in this patient, subacute thyroiditis manifested as a paraneoplastic syndrome of renal cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12695381      PMCID: PMC152681     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  9 in total

1.  Renal cell carcinoma: natural history and chemotherapeutic experience.

Authors:  J J Lokich; J H Harrison
Journal:  J Urol       Date:  1975-09       Impact factor: 7.450

2.  Interleukin-6 and renal cell cancer: production, regulation, and growth effects.

Authors:  A S Koo; C Armstrong; B Bochner; T Shimabukuro; C L Tso; J B deKernion; A Belldegrum
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 3.  Renal-cell carcinoma.

Authors:  R J Motzer; N H Bander; D M Nanus
Journal:  N Engl J Med       Date:  1996-09-19       Impact factor: 91.245

Review 4.  Renal cell carcinoma: a paradigm of lanthanic disease.

Authors:  R J Papac; W J Poo-Hwu
Journal:  Am J Clin Oncol       Date:  1999-06       Impact factor: 2.339

5.  Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinoma.

Authors:  J Y Blay; J F Rossi; J Wijdenes; C Menetrier-Caux; S Schemann; S Négrier; T Philip; M Favrot
Journal:  Int J Cancer       Date:  1997-07-29       Impact factor: 7.396

6.  Interleukin-6: a marker of thyroid-destructive processes?

Authors:  L Bartalena; S Brogioni; L Grasso; T Rago; P Vitti; A Pinchera; E Martino
Journal:  J Clin Endocrinol Metab       Date:  1994-11       Impact factor: 5.958

7.  Serum interleukin-6 in amiodarone-induced thyrotoxicosis.

Authors:  L Bartalena; L Grasso; S Brogioni; F Aghini-Lombardi; L E Braverman; E Martino
Journal:  J Clin Endocrinol Metab       Date:  1994-02       Impact factor: 5.958

8.  Relationship of the increased serum interleukin-6 concentration to changes of thyroid function in nonthyroidal illness.

Authors:  L Bartalena; S Brogioni; L Grasso; F Velluzzi; E Martino
Journal:  J Endocrinol Invest       Date:  1994-04       Impact factor: 4.256

9.  Dissociation between serum interleukin-6 rise and other parameters of disease activity in subacute thyroiditis during treatment with corticosteroid.

Authors:  T Yamada; A Sato; T Aizawa
Journal:  J Clin Endocrinol Metab       Date:  1996-02       Impact factor: 5.958

  9 in total
  1 in total

1.  Nonconstrictive epicarditis mimicking a cardiac mass in a 71-year-old Caucasian man: a case report and review of the literature.

Authors:  Asa M Margolis; Andrew B Emmerman; Mario Rascon; Saima I Chaudhry
Journal:  J Med Case Rep       Date:  2009-01-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.